Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Tesaro Inc (TSRO)

Tesaro Inc (TSRO)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 4,126,323
  • Shares Outstanding, K 55,047
  • Annual Sales, $ 223,330 K
  • Annual Income, $ -496,130 K
  • 60-Month Beta 0.38
  • Price/Sales 18.81
  • Price/Cash Flow N/A
  • Price/Book N/A
Trade TSRO with:
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -11.86
  • Most Recent Earnings -2.49 on 11/01/18
  • Next Earnings Date 02/26/19
  • Annual Dividend & Yield 0.00 (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Analyst Rating / Earnings Estimates

Current Rating
See More
Hold
Based on 17 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/18
See More
  • Average Estimate -2.45
  • Number of Estimates 9
  • High Estimate -2.28
  • Low Estimate -2.89
  • Prior Year -3.35
  • Growth Rate Est. (year over year) +26.87%

Price Performance

See More
Period Period Low Period High Performance
1-Month
72.59 +3.26%
on 12/21/18
75.16 -0.27%
on 12/28/18
+1.50 (+2.04%)
since 12/18/18
3-Month
23.41 +220.21%
on 11/09/18
75.16 -0.27%
on 12/28/18
+31.98 (+74.41%)
since 10/18/18
52-Week
23.41 +220.21%
on 11/09/18
75.16 -0.27%
on 12/28/18
+11.46 (+18.05%)
since 01/18/18

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Buy with a Strengthening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

The market is in highly overbought territory. Beware of a trend reversal.

See More Share

Business Summary

Tesaro, Inc. is an oncology-focused biopharmaceutical company for cancer patients. The Company's product portfolio consists of Rolapitant, a neurokinin-1 receptor antagonist for the prevention of chemotherapy induced nausea and vomiting, TSR-011, an orally available anaplastic lymphoma kinase inhibitor...

See More

Key Turning Points

3rd Resistance Point N/A
2nd Resistance Point 74.99
1st Resistance Point 74.97
Last Price 74.96
1st Support Level 74.94
2nd Support Level 74.93
3rd Support Level N/A

See More

52-Week High 75.16
Last Price 74.96
Fibonacci 61.8% 55.39
Fibonacci 50% 49.29
Fibonacci 38.2% 43.18
52-Week Low 23.41

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar